{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:32:36Z","timestamp":1787927556410,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104966","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:49:20Z","timestamp":1781711360000},"page":"104966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRT-064040: A nasal spray of novel, potent, and selective calcitonin gene-related peptide receptor antagonist for migraine"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5048-9222","authenticated-orcid":false,"given":"Shuwen","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anle","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-641X","authenticated-orcid":false,"given":"Dewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0353-7312","authenticated-orcid":false,"given":"Zhenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","article-title":"Migraine","volume":"8","author":"Ferrari","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s10194-023-01546-9","article-title":"The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable","volume":"24","author":"Hus\u00f8y","year":"2023","journal-title":"J Headache Pain"},{"issue":"4","key":"10.1016\/j.jpet.2026.104966_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpet.2026.104966_bib4","doi-asserted-by":"crossref","first-page":"2056786","DOI":"10.1155\/2016\/2056786","article-title":"Heteroreceptors modulating CGRP release at neurovascular junction: Potential therapeutic implications on some vascular-related diseases","volume":"2016","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2016","journal-title":"Biomed Res Int"},{"issue":"6683","key":"10.1016\/j.jpet.2026.104966_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpet.2026.104966_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0333102418765787","article-title":"Molecular studies of CGRP and the CGRP family of peptides in the central nervous system","volume":"39","author":"Hendrikse","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpet.2026.104966_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-823357-3.00024-0","article-title":"CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention","volume":"199","author":"Caronna","year":"2024","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104966_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg7380","article-title":"Activation of CGRP receptor-mediated signaling promotes tendon-bone healing","volume":"10","author":"Zhao","year":"2024","journal-title":"Sci Adv"},{"issue":"8008","key":"10.1016\/j.jpet.2026.104966_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41586-024-07237-y","article-title":"CGRP sensory neurons promote tissue healing via neutrophils and macrophages","volume":"628","author":"Lu","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jpet.2026.104966_bib10","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.immuni.2025.05.018","article-title":"Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo","volume":"58","author":"Yang","year":"2025","journal-title":"Immunity"},{"issue":"8059","key":"10.1016\/j.jpet.2026.104966_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41586-025-08591-1","article-title":"Nociceptive neurons promote gastric tumour progression via a CGRP-RAMP1 axis","volume":"640","author":"Zhi","year":"2025","journal-title":"Nature"},{"issue":"772","key":"10.1016\/j.jpet.2026.104966_bib12","doi-asserted-by":"crossref","first-page":"eadk8230","DOI":"10.1126\/scitranslmed.adk8230","article-title":"Nociceptor-to-macrophage communication through CGRP\/RAMP1 signaling drives endometriosis-associated pain and lesion growth in mice","volume":"16","author":"Fattori","year":"2024","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib13","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","article-title":"The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer","volume":"15","author":"Hou","year":"2024","journal-title":"Nat Commun"},{"issue":"6734","key":"10.1016\/j.jpet.2026.104966_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.adr4731","article-title":"Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes","volume":"387","author":"Cho","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41398-025-03229-2","article-title":"Adrenomedullin 2 attenuates anxiety-like behaviors by increasing IGF-II in amygdala and re-establishing blood-brain barrier","volume":"15","author":"Wang","year":"2025","journal-title":"Transl Psych"},{"issue":"14","key":"10.1016\/j.jpet.2026.104966_bib16","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1021\/acs.jmedchem.5c01120","article-title":"Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment","volume":"68","author":"Zong","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2026.104966_bib17","doi-asserted-by":"crossref","first-page":"102271","DOI":"10.1016\/j.molmet.2025.102271","article-title":"Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept","volume":"102","author":"Briere","year":"2025","journal-title":"Mol Metab"},{"issue":"10499","key":"10.1016\/j.jpet.2026.104966_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(25)01185-7","article-title":"Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b\/2a randomised controlled study","volume":"406","author":"Dahl","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpet.2026.104966_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1468-2982.1994.1405320.x","article-title":"Neuropeptides in migraine and cluster headache","volume":"14","author":"Edvinsson","year":"1994","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.jpet.2026.104966_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/d41573-023-00182-x","article-title":"The pipeline and market for migraine drugs","volume":"23","author":"Chaudhari","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 2","key":"10.1016\/j.jpet.2026.104966_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/head.12183","article-title":"A review of needle-free sumatriptan injection for rapid control of migraine","volume":"53","author":"Rothrock","year":"2013","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.jpet.2026.104966_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1474-4422(22)00517-8","article-title":"Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial","volume":"22","author":"Lipton","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1-3","key":"10.1016\/j.jpet.2026.104966_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2007.08.014","article-title":"Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells","volume":"577","author":"Pin","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"10.1016\/j.jpet.2026.104966_bib24","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104966_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(90)90832-T","article-title":"Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells","volume":"119","author":"Van Valen","year":"1990","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jpet.2026.104966_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.107.130344","volume":"324","author":"Salvatore","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.jpet.2026.104966_bib27","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104966_bib28","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.bmcl.2013.04.012","volume":"23","author":"Chaturvedula","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2125.2009.03543.x","article-title":"Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)","volume":"69","author":"Sinclair","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"5-6","key":"10.1016\/j.jpet.2026.104966_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000502471","article-title":"The Presence of Calcitonin Gene-Related Peptide and Its Receptors in Rat, Pig and Human Brain: Species Differences in Calcitonin Gene-Related Peptide Pharmacology","volume":"104","author":"Warfvinge","year":"2019","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.jpet.2026.104966_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/10717544.2012.762435","article-title":"Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects","volume":"20","author":"Nave","year":"2013","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.jpet.2026.104966_bib32","first-page":"451","article-title":"The pharmacokinetics of drugs delivered to the upper nasal space","volume":"37","author":"Shrewsbury","year":"2023","journal-title":"Pharmaceut Med"},{"issue":"18","key":"10.1016\/j.jpet.2026.104966_bib33","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1523\/JNEUROSCI.18-18-07581.1998","article-title":"Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat","volume":"18","author":"Michaelis","year":"1998","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.jpet.2026.104966_bib34","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/j.pain.0000000000003459","article-title":"Estrous cycle regulates cephalic mechanical sensitivity and sensitization of the trigemino-cervical complex in a female rat model of chronic migraine","volume":"166","author":"Barnet","year":"2025","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-025-03466-8","article-title":"Caveolin-1 negatively regulates the calcitonin receptor-like receptor and neuroinflammation in a female mouse model of migraine","volume":"22","author":"Zhou","year":"2025","journal-title":"J Neuroinflammation"},{"issue":"23","key":"10.1016\/j.jpet.2026.104966_bib36","doi-asserted-by":"crossref","first-page":"16876","DOI":"10.3390\/ijms242316876","article-title":"Dopaminergic projections from the hypothalamic A11 nucleus to the spinal trigeminal nucleus are involved in bidirectional migraine modulation","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10194-024-01739-w","article-title":"AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization","volume":"25","author":"Lu","year":"2024","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s10194-024-01837-9","article-title":"Brain-wide mapping of c-Fos expression in nitroglycerin-induced models of migraine","volume":"25","author":"Xiao","year":"2024","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231226186","article-title":"Pharmacologic characterization of atogepant: A potent and selective calcitonin gene-related peptide receptor antagonist","volume":"44","author":"Moore","year":"2024","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s10194-025-02066-4","article-title":"Induction of more severe central sensitization in a medication overuse headache model mice through active ingestion of rizatriptan","volume":"26","author":"Ma","year":"2025","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.jpet.2026.104966_bib41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0333102420938652","article-title":"Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache","volume":"40","author":"Navratilova","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpet.2026.104966_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105150","article-title":"Detailed comparison of anatomy and airflow dynamics in human and cynomolgus monkey nasal cavity","volume":"141","author":"Tian","year":"2022","journal-title":"Comput Biol Med"},{"issue":"13","key":"10.1016\/j.jpet.2026.104966_bib43","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1021\/acs.jmedchem.9b01810","article-title":"Blocking the CGRP pathway for acute and preventive treatment of migraine: The evolution of success","volume":"63","author":"Dubowchik","year":"2020","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.104966_bib44","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/bph.13783","article-title":"CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1","volume":"174","author":"Bohn","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"5997","key":"10.1016\/j.jpet.2026.104966_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"issue":"6185","key":"10.1016\/j.jpet.2026.104966_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/335073a0","article-title":"Substance P regulates the vasodilator activity of calcitonin gene-related peptide","volume":"335","author":"Brain","year":"1988","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib47","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.261065","article-title":"Characterization of ubrogepant: A potent and selective antagonist of the human calcitonin gene\u2012related peptide receptor","volume":"373","author":"Moore","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.109.163816","article-title":"Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist","volume":"333","author":"Salvatore","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpet.2026.104966_bib49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2125.2007.02939.x","article-title":"Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging","volume":"64","author":"Van der Schueren","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104966_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bcp.12547","article-title":"Characterizing the PK\/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist","volume":"79","author":"Li","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104966_bib51","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/head.13165","volume":"57","author":"Lipton","year":"2017","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.jpet.2026.104966_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/11317540-000000000-00000","article-title":"Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine","volume":"24","author":"Rapoport","year":"2010","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jpet.2026.104966_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40268-021-00360-5","article-title":"Improvement of intranasal drug delivery with Intravail\u00ae alkylsaccharide excipient as a mucosal absorption enhancer aiding in the treatment of conditions of the central nervous system","volume":"21","author":"Rabinowicz","year":"2021","journal-title":"Drugs R D"},{"issue":"12","key":"10.1016\/j.jpet.2026.104966_bib54","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1021\/acs.molpharmaceut.7b00297","article-title":"Dodecylmaltoside modulates bicellular tight junction contacts to promote enhanced permeability","volume":"14","author":"Gradauer","year":"2017","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s10194-022-01435-7","article-title":"CGRP and PACAP-38 play an important role in diagnosing pediatric migraine","volume":"23","author":"Liu","year":"2022","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.jpet.2026.104966_bib56","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/head.14389","article-title":"Zavegepant nasal spray for the acute treatment of migraine: A Phase 2\/3 double-blind, randomized, placebo-controlled, dose-ranging trial","volume":"62","author":"Croop","year":"2022","journal-title":"Headache"},{"key":"10.1016\/j.jpet.2026.104966_bib57","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.0000000000202067","article-title":"A phase 2\/3 open-label, long-term, safety trial of zavegepant 10 mg nasal spray for the acute treatment of migraine (P9-12.002)","volume":"100","author":"Croop","year":"2023","journal-title":"Neurology"},{"issue":"31","key":"10.1016\/j.jpet.2026.104966_bib58","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.2174\/0929867324666170303162416","article-title":"Family B G protein-coupled receptors and their ligands: From structure to function","volume":"24","author":"Liapakis","year":"2017","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.jpet.2026.104966_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1476-5381.2011.01633.x","article-title":"Targeting a family B GPCR\/RAMP receptor complex: CGRP receptor antagonists and migraine","volume":"166","author":"Moore","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104966_bib60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/acn3.197","article-title":"A second trigeminal CGRP receptor: function and expression of the AMY1 receptor","volume":"2","author":"Walker","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104966_bib61","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/ana.26072","article-title":"Amylin analog pramlintide induces migraine-like attacks in patients","volume":"89","author":"Ghanizada","year":"2021","journal-title":"Ann Neurol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:11:52Z","timestamp":1787926312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011651"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104966","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRT-064040: A nasal spray of novel, potent, and selective calcitonin gene-related peptide receptor antagonist for migraine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104966"}}